{"id":39796,"date":"2022-04-11T11:55:00","date_gmt":"2022-04-11T11:55:00","guid":{"rendered":"https:\/\/idafoundation.org\/?p=39796"},"modified":"2026-02-23T00:04:26","modified_gmt":"2026-02-23T00:04:26","slug":"invitation-to-bid-itb-on-behalf-of-stop-tb-gdf-2","status":"publish","type":"post","link":"https:\/\/idafoundation.org\/fr\/invitation-to-bid-itb-on-behalf-of-stop-tb-gdf-2\/","title":{"rendered":"Invitation to bid (ITB) on behalf of Stop TB\/GDF"},"content":{"rendered":"

UPDATE<\/strong> 26 April 2022 – Reminder<\/p>\n\n\n\n

Please be informed that for the ITB-IDA\/GDF – MED\/2022\/1, the deadline<\/strong> for submission\/modification of product\/s in FPP In-Market and\/or country registration in FPP registration modules, including uploading of supporting documents for GDF review\/approval is Wednesday 27 April 2022 at 19.00 CET<\/u>.<\/strong><\/p>\n\n\n\n

After this deadline<\/u><\/strong>, any submission\/modification of products and\/or country registration in both CDP modules by Bidders will NOT be reviewed\/approved by GDF.<\/p>\n\n\n\n

Please remember that after any submission\/modification of a product and\/or a country registration in both CDP modules, the status of the product \/ country registration will become \u201cpending\u201d and therefore not eligible to be selected for this tender via the CDP Portal under \u201cGDF Tender \/ Technical Tender Submission\u201d module. GDF will not be liable for the non-eligibility of product and\/or country registration for this tender if Bidder does not respect the above deadline.

_________________________________________________________________

11 April 2022 – Geneva, Switzerland – On behalf of Stop TB Partnership\u2019s Global Drug Facility (GDF), IDA Foundation (IDA), the GDF\u2019s contracted procurement agent, invites all eligible suppliers to submit bids for the following tender:<\/p>\n\n\n\n

ITB-IDA\/GDF-MED\/2022\/1<\/strong>, for the supply of antituberculosis (TB) medicines for the period 1 July 2022\u2013 31 December 2023<\/strong>.<\/p>\n\n\n\n

The purpose of the Invitation To Bid (ITB) is to select a panel of suppliers who will enter into a long-term agreement (LTA) with IDA for the supply of TB medicines.<\/p>\n\n\n\n

Only Bidders with products that comply with the GDF Quality Assurance Policy (https:\/\/www.stoptb.org\/suppliers\/quality-assurance<\/a>) are eligible to participate in this ITB.                                         
A bid submitted for product\/s for which the bidder has not received regulatory approval in accordance with the GDF Quality Assurance policy and procedures shall not be considered for the ITB evaluation.<\/p>\n\n\n\n

All bids are subject to the Instructions to Bidders and other provisions, specifications and instructions as contained in this ITB dossier.<\/p>\n\n\n\n

UPDATE 20 April 2022<\/strong>\u00a0– Some of our bidders requested clarification on this year’s ITB. Find the response here:\u00a0Q&A ITB-IDA\/GDF-MED\/2022\/1<\/a><\/p>\n\n\n\n

The ITB comprises of the following:<\/p>\n\n\n\n